Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic-onset juvenile idiopathic arthritis

Arthritis and Rheumatism

Volumn 58, Issue 3, 2008, Pages 869-874

  Donn, Rachelle ^a   Ellison, Stuart ^a   Lamb, Rebecca ^a   Day, Thomas ^a   Baildam, Eileen ^b   Ramanan, Athimalaipet V ^c,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^c BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^d ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; JUVENILE RHEUMATOID ARTHRITIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

ARTHRITIS, JUVENILE RHEUMATOID; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRANZYMES; HAPLOTYPES; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MACROPHAGE ACTIVATION; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PORE FORMING CYTOTOXIC PROTEINS; RAB GTP-BINDING PROTEINS; RISK FACTORS;

EID: 40549125931     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23270     Document Type: Article

References (15)

1. Schneider R, Laxer RM. Systemic onset juvenile rheumatoid arthritis [review]. Baillieres Clin Rheumatol 1998;12:245-71.
2. Wallace CA, Levinson JE. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s [review]. Rheum Dis Clin North Am 1991;17:891-905.
3. Ramanan AV, Grom AA. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology (Oxford) 2005;44:1350-3.
4. Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? [review]. Arthritis Rheum 2004;50:689-98.
5. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6.
6. Arlet JB, Le TH, Marinho A, Amoura Z, Wechsler B, Papo T, et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis 2006;65:1596-601.
7. Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007;34:1133-8.
8. Athreya BH. Is macrophage activation syndrome a new entity? Clin Exp Rheumatol 2002;20:121-3.
9. Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allergy Clin Immunol 2006;6:410-5.
10. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003;142:292-6.
11. Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005;7:R30-7.
12. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenbcrg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
13. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
14. Voskoboinik I, Sutton VR, Ciccone A, House CM, Chia J, Darcy PK, et al. Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. Blood 2007;110:1184-90.
15. Ioannidis JP, Trikalinos TA, Khoury MJ. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol 2006;164:609-14.